HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meryl Altree Selected Research

Breast Neoplasms (Breast Cancer)

10/2008Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
3/2006Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meryl Altree Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
10/2008 - 03/2006
1Neoplasms (Cancer)
01/2020
1Chromosomal Instability (Chromosome Stability)
03/2006
1Chromosome Aberrations (Chromosome Abnormalities)
03/2006

Drug/Important Bio-Agent (IBA)

1Core Binding Factor Alpha 2 SubunitIBA
01/2020
1HomocysteineIBA
10/2008
12- n- butyl- 3- (dimethylamino)- 5,6- methylenedioxyindeneIBA
10/2008
1Methionine (L-Methionine)FDA Link
10/2008
1Folic Acid (Vitamin M)FDA LinkGeneric
03/2006